regadenoson has been researched along with Cytokine Release Syndrome in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Al-Suqi, M; Brayman, KL; Chhabra, P; Conaway, MR; Fleischmann, E; Krupnick, A; Lau, CL; Linden, J; Mann, BJ; Mostafa, E; Rabin, J; Zhao, Y | 1 |
1 other study(ies) available for regadenoson and Cytokine Release Syndrome
| Article | Year |
|---|---|
Regadenoson for the treatment of COVID-19: A five case clinical series and mouse studies.
Topics: Animals; COVID-19; Cytokine Release Syndrome; Cytokines; Mice; Natural Killer T-Cells; Receptor, Adenosine A2A; SARS-CoV-2 | 2023 |